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Objectives. Quantification of myocardial blood flow (MBF) and stress/rest flow reserve is
used increasingly to diagnose multi-vessel coronary artery disease and micro-vascular disease
with PET imaging. However, variability in the measurements may limit physician confidence to
direct revascularization therapies based on specific threshold values. This study evaluated the
effects of rubidium-82 (82Rb) tracer injection profile using a constant-activity-rate (CA) vs a
constant-flow-rate (CF) infusion to improve test–retest repeatability of MBF measurements.
Method. 22 participants underwent single-session 82Rb dynamic PET imaging during rest and
dipyridamole stress using one of 2 test–retest infusion protocols: CA–CA (n 5 12) or CA–CF
(n 5 10). MBF was quantified using a single-tissue-compartment model (1TCM) and a simplified
retentionmodel (SRM).Non-parametric test–retest repeatability coefficients (RPCnp)were compared
between groups.Myocardium-to-blood contrast and signal-to-noise ratios of the late uptake images (2
to 6 minutes) were also compared to evaluate standard myocardial perfusion image (MPI) quality.
Results. MBF values in the CA–CA group were more repeatable (smaller RPCnp) than the
CA–CF group using the 1TCM at rest alone, rest and stress combined, and stress/rest reserve
(21% vs 36%, 16% vs 19%, and 20% vs 27%, P < 0.05, respectively), and using the SRM at Rest
and Stress alone, Rest and Stress combined, and stress/rest reserve (21% vs 38%, 15% vs 25%,
22%vs 38%, and 23%vs 49%,P < 0.05, respectively). In terms of image quality,myocardium-to-
blood contrast and signal-to-noise ratios were not significantly different between groups.
Conclusions. Constant-activity-rate ‘square-wave’ infusion of 82Rb produces more repeat-
able tracer injection profiles anddecreases the test–retest variability ofMBFmeasurements,when
compared to a constant-flow-rate ‘bolus’ administration of 82Rb, especially with SRM, and
without compromising standard MPI quality. (J Nucl Cardiol 2016)
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Absolute myocardial blood flow (MBF) quantifica-
tion addresses the limitation of relative myocardial
perfusion imaging (MPI) by measuring blood flow in
absolute units of mL/min per gram of tissue (mL/min/g),
with proven precision and accuracy1,2 and incremental
prognostic value.3,4 MBF quantification with rubidium-
82-chloride (82Rb) positron emission tomography (PET)
requires minimal changes to the conventional image
acquisition protocol, with no additional risk or discomfort
to patients. A series of dynamic PET images are acquired
starting at the time of tracer administration to measure the
time course of tracer clearance from arterial blood and
uptake into the myocardium. Tracer kinetic modeling
analysis is then used to estimate MBF based on the rate of
tracer uptake measured in the dynamic image sequence.
To enable high diagnostic confidence in the MBF
measurements, the test–retest repeatability should have
low variance, which is dependent on several factors during
image acquisition and analysis.We have previously shown
that automation of processing helps to minimize operator-
induced variability,5 and standardized analysis protocols
are reproducible between laboratories.6 In theory, tracer
kinetic analysis should be robust against variations in the
shape of tracer injection profiles; however, in practice, the
estimated kinetic parameters may be biased due to limita-
tions in instrumentation andmodeling assumptions.7 There
are limited studies investigating the influence of tracer
infusion profiles on MBF quantification.8,9
82Rb is the PET tracer used most commonly for clinical
MPI, and its use is growing for MBF quantification. Test-
retest repeatability of MBF imaging has been reported in the
range of 25% to 40% using dipyridamole10–12 and 25% to
30% using regadenoson stress.13 Due to the short radioactive
half-life (76 second) of the generator-produced 82Rb isotope,
the tracer must be eluted directly to the patient through an
intravenous (IV) catheter. The shape of the eluted activity
profile vs time can vary dramatically over the life of the
generator, as the parent 82Sr isotope decays. We previously
reported the performance of a custom elution system to allow
accurate administration of 82Rb activity using variable flow
rates within a preset time interval, e.g., 30 second ‘slow-
bolus’ infusions.14 Subsequent developments have aimed to
improve the repeatability of tracer infusionprofiles thatwould
otherwise changewith the ageof the 82Sr/82Rbgenerator.This
infusion system now employs a generator bypass-line and a
feedback-control system to achieve two key features: (1)
administration of 82Rb activity at a constant activity rate
(MBq/s) toavoid saturating thePETdetectorsduringdynamic
image acquisition, and (2) repeatable ‘square-wave’ 82Rb
activity profiles with progressive generator aging.
The primary goal of this work was to characterize the
influenceofvariable tracer infusionprofileson the test–retest
repeatability of MBF quantification, using two common
tracer kinetic models: (1) the single-tissue-compartment
model (1TCM)15 and (2) a simplified retention model
(SRM).16,17 A secondary goal was to evaluate the effect of
tracer infusion profiles on standard MPI signal-to-noise and
contrast asmeasures of image quality.We hypothesized that
MBF estimates may be dependent on the shape of the tracer
infusion profiles, and that the test–retest variability of MBF
quantificationmay be reduced by infusing 82Rb at a constant
activity rate (CA) vs a constant flow rate (CF), without a
significant impact on standard perfusion image quality.
MATERIALS AND METHODS
Study Population
This study consisted initially of 24 participants: 15 clinical
patients with known or suspected coronary artery disease (CAD)
and 9 healthy subjects with low risk of CAD.18 Patients with
acute coronary syndrome or unstable angina, heart failure,
pulmonary edema, severe valve disease, or contraindication to
dipyridamole such as hypotension, heart block, or asthma were
excluded. One healthy subject was excluded due to interstitial
tracer injections resulting from poor IV cannulation, and one
clinical patient was excluded due to paced rhythm that was
discovered following enrolment. Subjects were instructed to
abstain from caffeine intake for 12 hours, fast for 4 hours (except
for water intake), and withhold cardiac medications prior to the
study, according to our clinical protocol and society guidelines.19
All participants provided written informed consent to participate
See related editorial, doi:10.1007/s12350-
016-0690-1.
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under a research protocol approved by the University of Ottawa
Heart Institute Human Research Ethics Board.
Image Acquisition
Our standard clinical imaging protocol20 was modified to
acquire two rest and two stress (test–retest) scans in a single
imaging session, to maintain consistent patient positioning and
hemodynamic conditions. Patientswere positioned in aDiscovery
690 PET/VCT-64 scanner (GE Healthcare, Waukesha, WI) with
ECG leads placed for patient monitoring and cardiac gating. A
scout scan was performed for patient positioning, followed by a
low-dose [0.14 to 0.37 mSv] (median 0.26 mSv) CT scan for
attenuation correction. Four list-modePET scanswere acquired in
3D-mode; two scans at rest and two during dipyridamole-induced
hyperemic stress. 82Rb was administered over a 30-second
interval as a standard ‘square-wave’ infusion using the CA
elution mode for the first (test) rest and stress scans, according to
our routine clinical practice (Ruby-Fill generator and prototype
Rb-82 elution system [v2], Jubilant DraxImage, Kirkland, QC).20
For the second (retest) rest and stress scans, either the same CA
infusion or a 30 mL/min CF ‘bolus’ infusion mode was used.
For all scans, the injected activity was adjusted for patient
weight (10 MBq/kg) to limit the scanner coincidence dead-time
to\35% and the corresponding dead-time correction factors
(DTF\ 1.54) to ensure accurate measurement of the bolus first-
pass activity.21 82Rb PET images were aligned with the CT
images for accurate attenuation correction prior to dynamic
image reconstruction. List-mode scans (6 minute) were rebinned
into 14 time frames (9 9 10, 3 9 30, 1 9 60, 1 9 120 seconds)
and reconstructed using the vendor iterative algorithm (OSEM24
subsets, 4 iterations) and 8 mm Hann post-filter.
Tracer Infusion
Participants were randomly assigned to one of two groups
to avoid selection bias. In the CA–CA group, all four scans (test
and retest at rest and stress) were performed using the CA
infusion mode. In the CA–CF group, imaging was performed
using the CA infusion mode for the first (test) rest and stress
scans, and the CF infusion mode for the second (retest) rest and
stress scans. CA infusions were always performed first to
conform to our standard clinical imaging protocol. CF infusions
were performed at the maximum flow rate of 30 mL/min, to
achieve the shortest possible bolus infusion. All scans were
initiated manually after 82Rb infusion was started, and the
scanner-reported coincidence (prompt) count rates exceeded
10 kcps. The first rest scan was followed immediately by a
second rest scan. The stress agent, dipyridamole (0.14 mg/kg/
min), was infused for 5, and 3 minutes later, the two stress scans
were performed in rapid succession, as illustrated in Figure 1.
Image Quality
Since MPI is currently the standard for clinical interpreta-
tion, the effect of CAvsCF infusion profiles on image quality was
also evaluated. Several metrics were utilized: the total coinci-
dence (prompt) counts recorded during the 2 to 6 minutes
retention phase, the left ventricle (LV) activity polar map
myocardium-to-blood ratio (MBR), contrast-to-noise ratio
(CNR), and the myocardium signal-to-noise ratio (SNR). LV
activity polar maps were sampled from the 2 to 6 minutes
retention-phase images using FlowQuant V2.4 (UOHI, Ottawa,
ON).MBRwas defined as themean tracer activity in the LVpolar
map divided by the arterial blood value during the same time
frames (2 to 6 minutes). A higher MBR value indicates a higher
retention of radioactive tracer in the myocardium with respect to
the residual activity in the blood. A narrower peak of the bolus
first-pass in the blood input using the CF elution mode might
improve the MBR due to longer blood clearance time, but may
also increase the PET detector dead-time losses; therefore, the
peak dead-time correction factor (DTF) was also recorded. SNR
was computed as the mean/standard deviation (SD) of the
myocardium activity polar map. CNR was defined as the mean
(myocardium—blood) contrast divided by the SD of the
myocardium value in the LV activity polar map. Higher CNR
and SNR are indicative of lower image noise and higher
uniformity of tracer retention in the myocardium.
Myocardial Blood Flow
Reconstructed dynamic PET image sequenceswere analyzed
with FlowQuant to quantify MBF in the 3 vascular territories
using the 1TCM with dual-spillover correction and tracer extrac-
tion correction, previously shown to have good test–retest
repeatability at rest.10 This method includes automatically derived
left ventricle orientation and segmentation with optional operator
adjustments. The arterial blood volume of interest was automat-
ically derived by thresholding segmentation of the peak-activity
bloodpool image in a restricted region including the left atriumand
aortic outflow tract as described previously.10 A second kinetic
model, the SRM was also used to quantify MBF using the same
regions described above, as reported previously using a fixed
recovery coefficient (RC = 0.76), a blood integration interval
from time zero to the blood peak-time ? 1.4 minutes, and an
extraction correction consistent with the 1TCM values of MBF.17
STATISTICAL ANALYSIS
Continuous and discrete data are presented as mean ±
standard deviation (SD) and range [minimum, maximum] or
median and inter-quartile range (IQR) for non-Gaussian-
distributed data. Demographic and hemodynamic variables
were compared using unpaired or paired Student’s t-tests, with
Bonferroni corrections as appropriate. test–retest MBF values
were compared using Spearman’s rank correlation (R). Dif-
ferences in repeated measurements were calculated both in
absolute units (retest–test) mL/min/g, and relative to the test–
retest mean values [(retest - test)/(retest ? test)/2 9 100%].
The measured test–retest MBF differences did not follow a
Gaussian distribution so non-parametric repeatability coeffi-
cients (RPCnp=1.459IQR) were used as a more robust measure
to characterize the repeatability. For Gaussian-distributed data,
the conventional RPC=1.969SD and RPCnp are equivalent.
22
To account for small measured differences in the test–retest
values measured separately at Rest and Stress, repeatability of
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the combined Stress & Rest data was assessed using values
adjusted for the median differences. Changes in the heart
rate 9 systolic blood pressure = rate 9 pressure product
(RPP) between test and retest were compared to differences
in MBF using Spearman’s rank correlation. Wilcoxon and
Levene’s non-parametric tests were used to assess the statis-
tical significance of differences in medians and variances,
respectively. P values less than 0.05 were considered statis-
tically significant. All analyses were performed using Matlab
R2013b (Mathworks, Natick, MA).
RESULTS
Study Population
Demographics and cardiac risk factors for the
patients and normal volunteers are summarized in
Table 1. The CA–CF cohort had a higher number of
healthy normals who tended to be younger with lower
BMI than the CA–CA subjects. Hemodynamic measure-
ments are summarized in Table 2. As expected during
Figure 1. Test–retest 82Rb PET imaging protocol. A 30 seconds constant-activity-rate (CA) ‘square-wave’ infusion
was used for both test–retest scans in the CA–CA cohort, whereas a 30 mL/min constant-flow-rate (CF) ‘bolus’
infusion was used for the retest scans in the CA–CF cohort.
Table 1. Demographics and cardiac risk factors
CA–CA cohort CA–CF cohort P value
Total subjects (n) 12 10
Healthy normals (n) 2 6 0.04
Sex (male) 6 3 0.34
Age (mean ± SD [range]) years 62.2 ± 9.6 [47, 81] 54.3 ± 12.3 [25, 67] 0.11
BMI (mean ± SD [range]) m2/kg 32.5 ± 6.1 [24, 43] 28.1 ± 4.2 [22, 34] 0.06
Diabetic (No/Type 1 DM/Type 2 DM) 10/1/1 10/0/0 0.2/0.4/0.4
Smoker (Never/current/past[1 year) 6/3/3 9/0/1 0.4/0.1/0.4
Single vessel disease (n) 3 1 0.36
Multi-vessel disease (n) 1 0 0.40
LV ejection fraction at rest (%) 55 ± 9 62 ± 7 0.06
LV ejection fraction at stress (%) 64 ± 10 70 ± 3 0.06
BMI body mass index (height2/weight)
Type 1 DM insulin-dependent diabetes mellitus
Type 2 DM non-insulin-dependent diabetes mellitus
Table 2. Hemodynamic parameters (mean ± SD)
n 5 22
Rest Stress
Test Retest Test Retest
HR (bpm) 66.3 ± 9.7 65.2 ± 9.0 92.1 ± 14.2* 85.5 ± 11.3*
Systolic BP (mmHg) 129.9 ± 19.2 128.4 ± 17.6 137.8 ± 23.3* 129.5 ± 19.5
Diastolic BP (mmHg) 76.0 ± 8.9 75.1 ± 7.3 82.3 ± 13.8* 73.9 ± 10.3
RPP (bpm 9 mmHg) 8700 ± 2263 8435 ± 1995 12769 ± 3309* 11162 ± 2648*
HR heart rate, BP blood pressure, RPP rate pressure product (HR 9 systolic BP), bpm beats per minute, mmHg millimeters of
mercury
* P\0.05 increase during stress vs rest
 P\0.05 decrease during retest vs test
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pharmacologic stress, there were significant increases in
HR, BP, and RPP vs the resting state values. There were
no changes in resting hemodynamics between test and
retest; however, at stress, there was a small decrease
observed in all the hemodynamic values during the retest
scans compared to the initial stress test scans (P\ 0.05).
Retest vs test RPP values were highly correlated
(R C 0.90; P\ 0.001), showing a small but significant
decrease both at rest and stress (Figure 2A). The test–
retest changes in MBF (Delta) were not significantly
correlated with changes in RPP (R\ 0.30; P = NS) as
shown in Figure 2B using 1TCM, nor with SRM (data
not shown), therefore no RPP-adjustments of rest or
stress MBF values were performed.
Tracer Infusion
Depending on the amount of 82Rb activity available
from the 82Sr/82Rb generator and the amount of
requested activity, the CF-mode of elution resulted in
variable time intervals and peak amplitudes of tracer
activity, as illustrated in Figure 3. In contrast, the CA-
mode elution profiles were much less variable in shape,
with very consistent weight-adjusted amplitude over the
time course of infusion.
Image Quality
Comparison of the image quality metrics between
the CA vs CF infusions in the CA–CF cohort (n = 10) is
summarized in Figure 4. The CA ‘square-wave’ infu-
sions had significantly lower peak DTF values compared
to the CF ‘bolus’ infusions (1.43 ± 0.10 vs 1.51 ± 0.12;
P\ 0.001). A larger proportion of CF scans was above
the target dead-time factor (1.54) and correction inac-
curacy recommended on the particular PET scanner used
in this study (8/20 vs 2/20, P = 0.01) as shown in
Figure 5A; likely due to the higher injected activity rates
as shown in Figure 3. The total coincidence (prompt)
counts recorded in the uptake phase were[10% higher
(69 vs 62 M; P\ 0.001) using the CA vs CF infusion
Figure 2. Hemodynamic measurements during test and retest scans. (A) Very good
correlation of retest vs test heart rate 9 systolic blood-pressure product (RPP) at rest and
stress, and (B) no significant correlation of test–retest (Delta) changes in MBF (using 1TCM)
vs changes in RPP at rest or stress.
Figure 3. 82Rb infusion profiles for the CA–CF test–retest
cohort. The CA-mode elution profiles follow an approximate
‘square-wave’ infusion profile with a constant activity rate of
0.33 MBq/s/kg, resulting in a consistent total injected activity
of 10 MBq/kg (shaded blue area) administered over a standard
time interval of 30 seconds. The CF-mode profiles result in the
same total activity, but injected over variable time intervals
from 10 to 30 s and with variable peak amplitudes from 0.4 to
2.2 MBq/s/kg.
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mode. Despite this small increase in recorded counts,
there was no significant difference observed in the
uptake image quality metrics including MBR, CNR, and
SNR between CA and CF infusion modes (Figure 4).
Myocardial Blood Flow
Test–retest MBF scatter plots are shown in Figure 6
using consistent (CA–CA) and variable (CA–CF) infu-
sion profiles, as analyzed using the 1TCM and SRM
tracer kinetic methods. The CA–CA cohort (Figure 6A,
B) generally displayed test–retest values closer to the
line of identity (ideal) compared to the CA–CF values
(Figure 6C, D), using both the 1TCM and SRM meth-
ods. The measured range of MBF values was wider at
rest and stress in the CA–CF vs CA–CA group, due to
several outliers apparent in the CA–CF scatter plots,
using both the 1TCM and SRM methods.
The corresponding Bland–Altman plots of the
relative test–retest Delta/Mean [%] values are shown
in Figure 7, together with the 95% limits of agreement
(median ± RPCnp). The subjects with consistent tracer
infusion profiles (CA–CA cohort) generally had a
smaller range of mean MBF values at rest and stress,
with narrower limits of agreement (Figure 7A, B),
indicating improved test–retest repeatability.
The full list of test–retest median and RPCnp values
at Stress and Rest, as well as the combined Stress &
Rest, stress/rest, and stress–rest reserve values are
shown in Table 3; expressed both as absolute (delta)
and relative (delta/mean [%]) differences in MBF.
Significantly better test–retest variability (lower RPCnp)
was measured in the CA–CA vs CA–CF cohort at rest,
stress & rest combined, stress/rest, and stress–rest
reserve, using both the 1TCM and SRM analysis
methods (P\ 0.05). The test–retest variability was also
significantly lower at stress in the CA–CA vs CA–CF
cohort using the SRM analysis method.
Box-plots (median and IQR) and repeatability
coefficients (RPC) of the relative Delta/Mean [%]
values are illustrated in Figures 8A, B, respectively,
for stress, rest, stress & rest combined, stress/rest, and
stress–rest reserve. It is apparent that the CA–CA cohort
analyzed using the 1TCM method generally displayed
the smallest median delta and RPCnp values, as well as
the fewest outliers, whereas the CA–CF cohort analyzed
using the SRM method had the largest RPCnp values at
Stress, Rest, Stress & Rest combined, Stress/Rest, and
stress–rest reserve, as well as the largest outliers. Similar
patterns were observed in the RPCnp values using the
absolute scale differences, as shown in the Supplemen-
tary Figure S1.
Figure 4. Myocardial perfusion image quality in the CA–CF
cohort (mean ? SD). There were no significant differences in
myocardium-to-blood ratio (MBR), contrast-to-noise ratio
(CNR), and myocardial signal-to-noise ratio (SNR) between
CA vs CF infusion modes at rest or stress. There was a
significant improvement in MBR and CNR at stress vs rest, as
expected, using both infusion modes. *P\ 0.05 increased vs
rest.
Figure 5. System dead-time factors (DTF) effect on myocardial blood flow (MBF). (A) Correlation of DTF values for
paired rest (blue) and stress (red) scans using constant activity (CA) and constant flow (CF) infusions.Dotted lines are shown
at theDTFvalue of 1.54, corresponding to themaximum recommended dead-time limit of 35%.Differences inDTFbetween
infusion types did not correlate with changes in MBF, using either the 1TCM (B) or SRM (C) analysis method.
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While the peak DTF values were approximately 5%
higher using CF compared to the corresponding CA-
mode values (Figure 5A), there were no significant
differences in MBF observed as a result of changing
DTF values using either the 1TCM or SRM (Figure 5B,
C, respectively). The single outlier at stress observed
using the SRM (Figures 5C, 6D) did not appear as an
outlier using the 1TCM (Figures 5B, 6C), and therefore
cannot be attributed to changes in dead-time alone.
DISCUSSION
To the best of our knowledge, this is the first study
to evaluate the impact of tracer administration profiles
on the test–retest repeatability of MBF quantification
using dynamic 82Rb PET imaging. This work demon-
strates that the 82Rb tracer infusion profile can be a
significant source of variability in measured MBF
values, and that precision can be improved using the
more consistent CA infusion mode. Variability in the
combined Stress&Rest MBF and Reserve measurements
was substantially lower on average (20% vs 27% RPCnp)
when using consistent infusions (CA–CA) compared to
variable infusion profiles (CA–CF), with the 1TCM
analysis method (Table 3). This improvement in
repeatability was even more pronounced when using
the SRM kinetic analysis method (25% vs 52% RPCnp),
which appears to be more sensitive to changes in the
shape of the infusion profile than the 1TCM approach.
The widely used 1TCM appears to be more robust to
Figure 6. Retest vs test MBF values at rest and stress using the single-tissue compartment
model (1TCM) and the simplified retention model (SRM).
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variations in the infusion profile than the simple reten-
tion model, but neither model fully corrected for
unexpected changes in the shape of the arterial blood
input function. In theory, the quantitative MBF results
should not depend on the shape of the input function,
because the compartment model is formulated to predict
the myocardial tissue response curve for any arbitrary
shape of input. However, our results show that in
practice, there is still some residual bias which can be
reduced by standardizing the shape of the blood input
function. Conversely, the simplified retention model
does not predict the myocardial tissue response curve
explicitly, and is therefore more reliant on a consistent
shape of input function to provide repeatable measure-
ments of MBF. While the repeatability of MBF
quantification improved with consistent infusion pro-
files, it is equally important to note that the quality of the
late-phase uptake images was not adversely affected
using longer infusions.
Using the Rb-82 elution system that delivers repro-
ducible ‘square-wave’ infusion profiles over the life of
the generator, our results suggest that the CA infusion
mode is preferable for optimal repeatability, in particular
when using the SRM for MBF quantification with 82Rb
PET. This finding is of clinical significance since non-
invasive MBF and flow reserve imaging is being used
increasingly as part of the routine clinical evaluation of
stress myocardial perfusion. The results of this study
indicate that the repeatability of MBF measurements
with 82Rb PET is improved using an elution system
capable of maintaining reproducible infusion profiles
irrespective of generator age.
MBF Tracer Kinetic Models
We evaluated the repeatability of MBF quantifica-
tion using two commonly employed methods: the single-
tissue-compartment kinetic model (1TCM) and a sim-
plified retention model (SRM). The 1TCM is widely
accepted in the community to be both accurate and
robust.1,2,6 Previous studies have shown good repro-
ducibility of the 1TCM for 82Rb MBF measurement, as










CA–CA 1TCM 0.95 0.16 (8.7) 0.25 (14)§
SRM 0.94 -0.13 (-8.1) 0.27 (15)*
CA–CF 1TCM 0.97 0.26 (9.4) 0.32 (11)
SRM 0.93 -0.02 (-0.6) 0.68 (25)
Rest
(mL/min/g)
CA–CA 1TCM 0.90 -0.06 (-7.7) 0.18 (21)*
SRM 0.91 -0.10 (-15) 0.16 (21)*
CA–CF 1TCM 0.88 -0.05 (-4.4) 0.32 (36)
SRM 0.92 -0.11 (-16) 0.37 (38)
Stress & rest
(mL/min/g)
CA–CA 1TCM 0.98 0 0.21 (16)*
SRM 0.98 0 0.17 (22)*
CA–CF 1TCM 0.94 0 0.34 (19)
SRM 0.97 0 0.42 (38)
Stress/rest
(ratio)
CA–CA 1TCM 0.87 0.07 (3.3) 0.40 (20)*§
SRM 0.87 -0.55 (-25) 0.74 (23)*
CA–CF 1TCM 0.74 0.03 (1.6) 0.66 (27)
SRM 0.86 -0.61 (-17) 1.75 (49)
Stress–rest
(mL/min/g)
CA–CA 1TCM 0.93 0.09 (8.9) 0.22 (24)*
SRM 0.91 -0.27 (-23) 0.26 (29)*
CA–CF 1TCM 0.77 0.13 (8.4) 0.49 (34)
SRM 0.53 -0.15 (-7.1) 0.79 (68)
Delta = retest-test; mean = (test ? retest)/2
 P\0.05 significant bias in the median delta vs zero
 Adjusted for the median rest and stress delta values
§ Lowest values for combined interpretation of stress and stress/rest MBF
* P\0.05 decreased variance in CA–CA vs CA–CF cohort
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implemented in several research and commercial soft-
ware packages.6,23 Simplified retention models may be
attractive due to the lower computational complexity but
suffer from relatively poor reproducibility among results
reported by various laboratories.17 For example, despite
the widespread acceptance of 82Rb and 13N-ammonia
PET imaging for the quantification of MBF, quite a wide
range of tracer retention fractions have been reported
(20 to 30% for 82Rb and 30 to 60% for 13N-ammonia at
peak stress) using several variations of a simple reten-
tion model, each with slightly different underlying
assumptions and numerical implementations.17
To date, there has been no study comparing the
1TCM vs SRM methods, in terms of MBF test–retest
repeatability. Although it was not the primary objective
of the present study, we observed substantially lower
test–retest variability using the 1TCM compared to SRM
in the CA–CF cohort, for the combined Stress&Rest
MBF and Reserve data (27% vs 52% RPCnp). However,
when using consistent infusion profiles (CA–CA), the
differences in repeatability between the 1TCM vs SRM
were smaller (20% vs 25% RPCnp) and did not reach
statistical significance. These findings support our
hypothesis that changes in the tracer infusion profile
shapes can adversely impact MBF variability and that a
reproducible infusion profile can help to reduce test–
retest variability, especially when assuming SRM
kinetics.
Outlier Values
The regression and Bland–Altman plots in Fig-
ures 6 and 7 suggest that one of the patients in the CA–
CF cohort appears to be a clear outlier. This is
particularly evident using the SRM method which
resulted in abnormally high mean MBF values of 3 to
4 mL/min/g at rest, and up to 6 mL/min/g at stress.
Several quality assurance metrics were investigated to
identify a potential cause; there was no significant
patient body motion or hemodynamic changes between
test and retest scans. The tracer elution profiles, had
substantially different shapes between the CA ‘square-
Figure 7. Bland–Altman plots of MBF repeatability at rest and stress. Retest–test delta/mean
[%] values are plotted at rest (blue) and stress (red) vs the respective Mean MBF [mL/min/g].
Median values are plotted as thick solid lines within the shaded regions illustrating the limits
of agreement of the median ± 1.45 9 IQR (inter-quartile range). Values are indicated as
median and [lower, upper] limits of agreement.
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wave’ vs CF ‘bolus’ infusion modes, but were highly
repeatable between rest and stress as shown in Supple-
mentary Figure S2. The corresponding blood input and
myocardium TACs for this particular patient are pre-
sented in Supplementary Figure S3. The initial rest scan
had a delayed rise in blood activity following the initial
bolus, which may be associated with an interstitial
infusion or partially blocked IV catheter. The second
rest and both stress scans had a similar delayed but
smaller-amplitude blood peak at approximately 1.5 min
following the initial bolus. The shape of the blood input
curves was reflected in abnormally long mean-transit-
times, as derived using a gamma-variate curve fit to the
first-pass blood peak activity. Consequently, tracer
delivery to the myocardium proceeded well beyond the
standard blood integration time of the SRM, leading to
substantial overestimation of the MBF values ([4 mL/
min/g) during the initial test scan at rest. In contrast, the
1TCM was better able to account for the complete shape
of the blood and myocardium TACs, resulting in more
repeatable MBF estimates despite the dramatic changes
in shape. These results suggest an improved ability of
the 1TCM to accommodate a wider range of arterial
blood and myocardium TAC shapes that may be
encountered in clinical practice.
Comparison to Previous Studies
Table 4 summarizes previously published repeata-
bility values for stress flow, rest flow, and flow reserve
using PET, compared with the results of the current
study. The values reported in this study are among the
lowest, which may benefit from our previous work on
minimizing several sources of variability including:
kinetic model parameters, image-derived blood input
ROI,10 and operator variability.5 In the current study, we
used these previously determined optimal parameters
and investigated the infusion profile shape as an addi-
tional source of variability. The present results
demonstrate that 82Rb PET MBF quantification using
the CA elution mode to deliver consistently shaped
infusion profiles can improve test–retest precision.
This work was performed using a high-count-rate
LYSO-based PET system. High-count-rate capabilities
are essential for MBF quantification with 82Rb due to the
wide range of count rates encountered over the course of
dynamic image acquisition, associated with rapid tracer
distribution and short radioactive half-life (76 s). This is
especially true in a clinical setting where high-quality
MPI (and ECG-gated) images are desired in addition to
dynamic imaging for MBF quantification using a single
tracer injection. CA infusions may prove to be even
more advantageous on lower count-rate systems (e.g.,
using BGO detectors) in which a tradeoff exists between
higher 82Rb activity required for diagnostic quality MPI
images, vs lower 82Rb activity to avoid detector dead-
time saturation in early time frames for accurate MBF
quantification.
Potential Limitations
This study enrolled a relatively small number of
subjects (n = 22). Nevertheless, we were able to
demonstrate a significant improvement in MBF repeata-
bility using a consistent CA-mode infusion of 82Rb
compared to variable CF-mode infusions, which demon-
strated changes in amplitude and duration as a function
of generator age and injected activity.
Figure 8. Test–retest RPCnp values of delta MBF [%] relative
to the mean. (A) Box-plots of the median and inter-quartile
range in the CA–CA and CA–CF cohorts, measured using the
1TCM and SRM methods; possible outliers shown with red
‘?’ symbols are beyond the median ± 1.5 9 IQR. (B)
Repeatability coefficients (RPCnp) in the CA–CA and CA–
CF cohorts, measured using the 1TCM and SRM methods.
*P\ 0.05 decreased variance in CA–CA vs CA–CF cohort.
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The present study did not investigate the test–retest
repeatability of the CF-mode infusions alone, with
variable shape profiles at the start and end of the
generator shelf-life, as may be encountered in clinical
practice. Our results suggest that the CA ‘square-wave’
infusion mode might be expected to improve MBF
repeatability compared to CF-mode studies performed
on different days, by removing the variations between
infusion profiles that typically occur as the generator
ages. This could be confirmed in a future study using
CA–CA vs CF–CF test–retest studies acquired on
different days within the normal generator shelf-life. In
the present study, we were bound by the need to comply
with our clinical-standard procedure for cardiac imaging
and MBF quantification using the established CA-mode
infusion, and selected a rapid test–retest protocol to
achieve stable hemodynamics, which could otherwise
affect the test–retest repeatability. Furthermore, the
protocol was limited to 4 scans per subject in order to
reduce participant discomfort and radiation exposure
(estimated to be an additional 1.5 mSv above the clinical
routine).30
Small differences in patient demographics between
the CA–CA and CA–CF cohorts (Table 1) were an
unintended consequence of our randomization strategy.
Nevertheless, we believe that the conclusions remain
valid since we evaluated the test–retest differences
relative to the mean for each subject, and using paired
comparisons in which each patient served as their own
control.
CONCLUSIONS
Myocardial blood flow quantification with 82Rb
PET can be influenced by the shape of the time-activity
infusion profile of the tracer. Constant-activity-rate
‘square-wave’ infusion of 82Rb produces more consis-
tent activity profiles and improves the test–retest
variability of MBF measurements, when compared to
constant-flow-rate ‘bolus’ administration of 82Rb, espe-
cially using the simplified retention model. Standard
MPI uptake-phase image quality was not influenced by
the variations in tracer infusion profiles.
NEW KNOWLEDGE GAINED
The reproducibility of myocardial blood flow quan-
tification from 82Rb dynamic PET may be influenced by
inconsistent tracer infusion profiles. The one-tissue
kinetic model is more robust to variations in tracer
infusion than the simplified retention model. Therefore,
a reproducible infusion profile over the life of a
82Sr/82Rb generator such as constant activity rate
(square-wave) is preferable, especially when using a










Kaufmann24 15O-water 10 minutes Adenosine 0.90 (25%) 0.17 (18%) 0.98 (34%)
Wyss25 15O-water 20 minutes Adenosine 1.34 (27%) 0.26 (21%) 1.44 (35%)
Siegrist26 15O-water 40 minutes Cold-Pressor 1.82 (NA) 1.47 (NA) NA
Schindler27 13N-ammonia 45 minutes Cold-Pressor 0.28 (32%) 0.26 (39%) 0.27 (23%)
Nagamachi28 13N-ammonia 50 minutes Adenosine 0.40 (20%) 0.13 (20%) NA
Manabe29 82Rb-chloride 60 minutes Adenosine
Triphosphate
0.92 (27%) 0.19 (24%) 1.61 (36%)
Sdringola30* 82Rb-chloride 22 days Dipyridamole 1.09 (41%) 0.24 (35%) 1.96 (51%)
Efseaff10 82Rb-chloride 15 minutes Dipyridamole NA 0.21 (25%) 0.58 (24%)**
Moody13*** 82Rb-chloride NA Regadenoson 0.51 (28%) 0.28 (26%) NA
Johnson12 82Rb-chloride NA Dipyridamole 0.76 (34%) 0.33 (39%) 0.94 (34%)
Klein§ 82Rb-chloride CA–CF 10 minutes Dipyridamole 0.32 (11%) 0.32 (36%) 0.66 (27%)
82Rb-chloride CA–
CA
10 minutes Dipyridamole 0.25 (14%) 0.18 (21%) 0.40 (20%)
NA not available
 Estimated from reported RPC of S-R difference
* 2-Week test–retest interval in ‘not normal’ cohort
** Estimated using test–retest variance at rest only
*** predicted ‘short-term’ RPC using analytical variance estimation in clinical patient scans
§ Using 1TCM analysis method in the present study
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simplified retention model. Conventional MPI quality is
not degraded by CA infusions.
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